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Abstract
Confined hydration and conformational flexibility are some of the challenges encountered for
the rational design of selective antagonists of G-protein coupled receptors. We present a set
of C3-substituted (-)-stepholidine derivatives as potent binders of the dopamine D3 receptor.
The compounds are characterized biochemically, as well as by computer modeling using a
novel molecular dynamics-based alchemical binding free energy approach which incorporates
the effect of the displacement of enclosed water molecules from the binding site. The free en-
ergy of displacement of specific hydration sites is obtained using the Hydration Site Analysis
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method with explicit solvation. This work underscores the critical role of confined hydra-
tion and conformational reorganization in the molecular recognition mechanism of dopamine
receptors and illustrates the potential of binding free energy models to represent these key
phenomena.
Introduction
One critical aspect of molecular recognition is the change in the hydration structure and
hydration energetics induced by ligand binding. [1–5] Water molecules trapped, for example,
in hydrophobic pockets within the binding site can be energetically disfavored as well as
entropically frustrated relative to bulk water. Hence, displacements of these water molecules
by the ligand can significantly enhance binding. [6–9] These effects are particularly impor-
tant when comparing a series of ligands of interest which differ in the way they displace
enclosed water molecules. The rational design of ligands using these principles can lead to
improvements of binding potency and receptor selectivity. [10]
There have been significant efforts towards the development of methodologies to model
the thermodynamic parameters and structural properties of water molecules at the protein
surfaces. [11–16] Most of these methods employ an explicit representation of the solvent,
which is considered the “gold standard” for modeling macromolecular complexes in part be-
cause of the capability of accurate representation of specific hydration environments. It is
challenging, however, to access the time scales required to sample the changes in hydra-
tion states and capturing the effects of water explusion from protein binding sites induced
by ligand binding. [14, 17–19] We have shown that the influence of confined hydration can
be also represented by a hybrid implicit solvent model trained on Hydration Site Analysis
(HSA) [6,8] data obtained with explicit solvation. [9] The primary purpose of this work is to
explore the applicability of our hybrid implicit solvent approach to protein-ligand systems.
The dopamine D3 receptor is an important medicinal target in which the ligand recognition
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mechanism is heavily influenced by hydration effects. Due to conformational variability, the
complexities of hydration and molecular interaction networks, and the lack of extensive struc-
tural information, it has been very challenging, using conventional drug design and modeling
approaches, to design selective antagonists against the dopamine D3 family of receptors. We
believe that molecular dynamics free energy approaches combined with accurate modeling of
hydration can be helpful in the design of more effective and more specific antagonists. [20–23]
Dopamine D3 receptors, which are part of the G-protein coupled receptor superfamily, are
increasingly important as drug targets for the treatment of a number of pathological condi-
tions such as Parkinson’s disease, schizophrenia and drug abuse. [24–26] Dopamine receptors
are classified under two families and five sub-types: the D1 family, comprising the D1R and
D5R receptors which stimulate the production of cAMP, and the D2 family, comprising the
D2R, D3R and D4R receptors which have inhibitory functions in cAMP production and
downstream signaling. While both these receptor families have been targeted for the treat-
ment of neurological disorders, it has been challenging to design specific antagonists within
the D2 receptor subfamily. Most of the drugs tested act as dual D2/D3 antagonists. [27–30]
D2 receptor antagonism has been associated with serious neurological side effects. [31,32] D3
receptors, on the other hand, which also have high affinity towards dopamine were observed
to significantly affect synaptic transmission and can be potential targets in the treatment of
neurological disorders , especially related to drug addiction and craving responses. [28,33,34]
The mechanism of antagonism of D3 receptors has been intensely studied to gain an
understanding of how to develop potent and selective antagonists. [21, 27, 29, 35, 36] The
crystal structure of the D3 receptor in complex with eticlopride, [27] a dual D2/D3 antagonist,
has been very helpful in understanding the intermolecular interactions in the orthosteric
binding site (OBS) of the D3 receptor. It also revealed a secondary binding site (SBS) which
is believed to be a critical molecular recognition site. A recent study has also suggested
the existence of a cryptic pocket in the orthosteric binding site (OBS) of the dopamine
D3 receptor. [35] These important discoveries have provided valuable information for the
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Figure 1: Crystal structure of the dopamine D3 receptor with Eticlopride bound at the
binding site [27]. This representation shows the approximate position of the orthosteric
binding site (OBS) with a blue oval and the secondary binding site (SBS) with a green oval.
development of D3 selective ligands. [21,22]
The orthosteric binding site (OBS) of D3 is surrounded by the helices III, V, VI and
VII comprising Ser 1925.42, Ser 1935.43, Ser 1965.46, Cys 1143.36, His 3496.55, Phe 3456.51, Phe
3466.52 and Val 1895.39 residues. The secondary binding site (SBS), also referred as the ex-
tracellular extension, is located at the interface of helices I, II, III, VII and the extracellular
loops ECL1 and ECL2 (Fig. 1). The OBS is conserved in both D2 and D3 receptors but
differ in the residue composition at the SBS. As exemplified by the structure of D3 bound
to eticlopride [27] (Fig. 1), the interaction of ligands to the OBS of D3 is characterized
by a salt-bridge between the carboxylate group of Asp 1103.32 in helix III of D3 and the
protonated amine group of eticlopride. This salt-bridge interaction is believed to be phar-
macologically crucial in binding of ligands at the OBS of dopamine D3 receptor and to other
dopaminergic receptors. [27] Previous studies have highlighted the challenges of designing
specific antagonists against the dopamine D3 receptor. [20,22,36]
In this study, we focus on the interaction of the D3 receptor with a series of derivatives
of (-)-stepholidine (Table 1), a natural product displaying dual D1 and D2 activity and
observed to have antipsychotic activities. [30, 37–39] Motivated by the previous work on
the synthesis and activity of the (-)-stepholidine C9 derivatives [22] aimed at achieving
a dual D1/D3 activity, we continued our Structure-Activity Relationship (SAR) studies
4
Figure 2: Structure of the (-)-stepholidine core with four rings annotated alphabetically as
referenced in the text. R1 represents the substitution at the C3 position. The chiral carbon
is labeled by a star.
using the tertrahydroprotoberberine (THPBs) scaffold to synthesize a new set of compounds
targeting the dopamine receptors. In comparison to the compounds previously assayed
which are substituted with alkyl chains at the C9 position of the THPB scaffold, compounds
synthesized and studied in this work are substituted at the C3 position (Fig. 2 and Table 1).
The motivation of synthesis and substitution at the C3 position is to extend these molecules
to access the secondary binding site (SBS) which have the potential to improve receptor
selectivity for these compounds. [22] Due to the lack of a crystal structure, the mode of
interaction of (-)-stepholidine derivatives with the D3 receptor remains uncertain. [22,29,40]
In this work, we report the first assessment of a novel computational strategy by using
an implicit solvent model to model the effects of water expulsion in protein-ligand binding.
This is done by acquiring the thermodynamic properties of binding site water molecules
in dopamine D3 receptor from explicit solvent simulations and estimating the binding free
energies of the complexes of (-)-stepholidine analogues’ with the D3 receptor by incorporating
hydration parameters in an implicit solvent model. This allowed us to capture localized
enclosed hydration effects which could not be captured by using conventional descriptions of
solvation.
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Table 1: List of the (-)-stepholidine derivatives considered in this work. All substitution are
made at the C3 position of the (-)-stepholidine core as shown in Fig. 2.
(-)-stepholidine C3 derivatives
x R1
1a H Et
1b H n-Pr
1c H n-Bu
1d H n-Pen
1e H n-Hex
1f H 2-fluoro ethyl
Methods
Hydration Site Analysis of the binding site of the D3 receptor
The thermodynamic and structural properties of water molecules in the binding site of
the receptor were studied using the Hydration Site Analysis (HSA) method. [8, 11] Briefly,
HSA is based on the analysis of molecular dynamics trajectories with explicit solvation,
whereby molecular dynamics simulations are performed to identify regions with significant
water density near the receptor surface. Average thermodynamic quantities such as enthalpy,
entropy and free energies are calculated for these sites using the concept of Inhomogeneous
Solvation Theory. [6, 41] HSA explicit solvent simulations are performed on a restrained
receptor structure. The trajectories are then processed to cluster hydration site locations
and analyzed for their thermodynamic estimates as described elsewhere. [6, 8] The total
energy, Etotal for each of these sites are calculated as the sum of the one-half of the mean
solute-water Esw interaction energy and one-half of the mean water-water Eww interaction
energy. The excess energies of the hydration sites relative to bulk value are used to classify
them as either favorable or unfavorable water sites. Unfavorable sites are those that, when
displaced by the ligand, are believed to enhance the binding affinity. The locations and
average solvation energies for each of the sites identified for the D3 receptor are shown in
Fig. 3a and Table 2.
Proteins can be highly dynamic. Hence, a single structure is often an insufficient repre-
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sentation of the structural variability of the hydration layer of a protein receptor. This is
particularly so in the present work, where the ligands we considered could induce different
conformations of the receptor when bound. To address conformational variability, in this
work, we obtained HSA hydration maps for a series of D3 receptor structures obtained from
induced-fit docking calculations with different ligand types including the available crystal
structure [27] (see Computational Details). The location and energies of the hydration sites
were averaged from all receptor conformations to obtain a single hydration map as shown in
Fig. 3a.
The solvation energies and locations of the explicit hydration sites were then used to
position the hydration spheres of the AGBNP2 implicit solvation model and to set their
strengths (1). The strength of the hydration spheres were set according to the HSA scores
[Etotal(i)− Ebulk]p(i) (1)
where i is the index of the HSA hydration sites, p(i) is the water occupancy of the site,
Etotal(i) is the total energy of the site and Ebulk is the corresponding reference value obtained
from OPC [42] neat water (Ebulk = −12.24 kcal/mol).
Parameterization of the AGBNP2 Enclosed Hydration Model
Even slight variations in atomic positions are known to cause significant changes in hydra-
tion structure. [10, 43, 44] We attempted to capture specific ligand-induced conformational
changes, as well as thermal fluctuations of the hydration structure by considering multiple
structures of the D3 receptor (see Computational Details). Hydration site maps were ob-
tained individually for each of the three receptor structures using HSA. [8] These hydration
maps were then integrated into a single hydration map (see Fig. 3a) by averaging the free
energy weights of neighboring hydration sites from the individual maps. The energies and
water occupancies of the HSA hydration regions were used to obtain the enclosed hydration
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Figure 3: (a) Location of hydration sites (red) within the binding cavity of the Dopamine
D3 receptor as mapped by Hydration Site Analysis. (b) Hydration spheres (green) of the
AGBNP2 model for the same receptor structure in (a). The positions of the AGBNP2
hydration spheres are functions of the internal coordinates of the receptor.
corrections for the AGBNP2 hydration spheres using eq. (1).
The energetically unfavorable hydration sites identified by HSA, and thus good candi-
dates for displacement by the ligand, were found to be distributed throughout the dopamine
D3 receptor binding site. These were reproduced as best as possible with AGBNP2 hy-
dration spheres within the limitations of the available anchoring methods. [9, 45] To ensure
translational and rotational invariance of the AGBNP2 implicit solvation function, hydration
spheres are located only in terms of molecular internal coordinates, that is by specifying dis-
tance and angle geometries in relation to selected atoms of the receptor. The geometries that
were employed most often in this work have been for sites attached to polar hydrogen atoms
and for sites anchored to mimic the lone pair orbitals of carbonyl and carboxylate groups.
When a suitable anchoring geometry could not be found, AGBNP2 hydration spheres have
been positioned at the geometrical center of a group of atoms of the receptor, typically back-
bone Cα, Cβ and N atoms (Fig. 4). [9] The resulting AGBNP2 hydration sites are shown in
Fig. 3b and their parameterization are listed in Table 2.
Because of the complexities of enclosed hydration phenomena and their variations due
to the motion of receptor atoms, it has been challenging to formulate an unsupervised and
8
Table 2: Summary of the placement and parameterization of the AGBNP2 enclosed hydra-
tion sites for the dopamine D3 receptor binding site.
Locationa HSA site
Idb
AGBNP2
site Idb
AGBNP2
anchoring type
c
pds (E − Ebulk)e (E − Ebulk)×psf
OBS 0 0,1 Asp 110
backbone
carbonyl
1.00 2.36 2.36
OBS 3,4,8,21 3,4,5 Asp 110 side
chain
carboxylate
0.86 3.28 2.83
OBS 25,26 9 Center of mass 0.66 1.92 1.27
OBS 14,19,41 12 Center of mass 0.57 5.32 3.05
OBS 1 13 Center of mass 0.87 2.80 2.44
OBS/SBS
boundary
11 10 Center of mass 0.83 2.32 1.92
OBS/SBS
boundary
9 18 Ser 182
hydroxyl
hydrogen
0.87 0.21 0.19
SBS 12 11 Center of mass 0.63 0.92 0.58
SBS 34,42 14 Center of mass 0.58 1.31 0.77
SBS 5 15 Center of mass 0.95 0.34 0.33
SBS 15 16 Center of mass 0.68 0.50 0.34
SBS 37 17 Center of mass 0.34 0.08 0.03
aOBS: Orthosteric binding site; SBS: Secondary binding site. bSite Id as shown in Fig. 3 cSee reference. dAverage water
occupancy of the site measured by HSA eAverage energy of the site relative to bulk measured by HSA, Ebulk = −12.24
kcal/mol. fOverall energy score of the HSA sites indicated in column 2 and of the enclosed hydration score of the AGBNP2
hydration spheres indicated in column 3 in kcal/mol.
automated protocol to map HSA results to AGBNP2 spheres. Within the general frame-
work outlined above, some manual adjustments were made. One adjustment was made to
model strongly unfavorable HSA hydration sites (HSA site Ids - 3,4,8 and 21) identified
at hydrogen-bonding distance to the carboxylate group of the critical Asp1103.32 residue.
Because AGBNP2 attaches eight equinergetic solvation spheres to carboxylate groups, [45]
we decided to distribute the HSA excess energy of this site among the three out of eight
carboxylate hydration spheres of Asp1103.32 with non-zero water occupancy. Adjustments
were also made to treat HSA hydration sites in close proximity to each other. Due to the
limitations in mapping accurately the position of AGBNP2 spheres, in these case, we mod-
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Figure 4: (a) Location of a hydration site identified by HSA using three receptor structures
(residues from one receptor structure shown for clarity); the overlapping red, yellow and
orange spheres represent a hydration site identified by each receptor structure; the energetic
penalties incurred from each HSAmap are annotated in kcal/mol, (b) An AGBNP2 hydration
sphere (green) is placed and scored by averaging the energetic penalties from the three maps
at the location of the HSA site; the AGBNP2 hydration sphere is placed at the geometrical
center of the atoms represented in CPK and is anchored to respective atoms during the
simulation.
eled nearby groups of HSA sites with a single AGBNP2 hydration sphere by assigning to it
the sum of the energy weights of each HSA site as shown in Table 2.
Binding free energy model
The protein-ligand complexes are modeled using the OPLS-AA/AGBNP2 effective potential,
in which the OPLS-AA [46,47] force field defines the covalent and non-bonded inter-atomic
interactions. Solvation effects are modeled implicitly using the Analytic Generalized Born
plus non-polar (AGBNP2) model. [45] According to this model, the hydration free energy
∆Gh of the receptor-ligand complex is computed as the sum of electrostatic ∆Gelec, non-
polar, ∆Gnp, and short-range solute-water interactions, ∆Ghs :
∆Gh = ∆Gelec + ∆Gnp + ∆Ghs (2)
The electrostatic component of the hydration free energy is computed using a modified
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continuum dielectric Generalized Born model. [48, 49] The non-polar component includes a
surface-area dependent term that accounts for the free energy of creating the solute cavity
within the solvent, and a Born-radius dependent term that accounts for long range solute-
solvent van der Waals interactions. [45] In AGBNP2, short-ranged solute-solvent interactions,
such as hydrogen bonding are modeled by means of hydration spheres placed on the solute
surface. A geometrical procedure measures the water occupancy of each hydration sphere,
which is then used to weigh its contribution to the solute hydration free energy according to
the expression:
∆Ghs =
∑
s
hsS(ws) (3)
where ws is the water occupancy factor of the sphere defined as
ws =
V frees
Vs
(4)
where Vs is the volume of each sphere and V frees is the volume of the portion of the sphere
occupied by water. S is a switching function that smoothly turns off an hydration sphere if
its water occupancy is below a given threshold. The hs parameter measures the hydration
strength of the corresponding hydration site. Negative hs values describe hydration sites
contributing favorably to the hydration free energy, whereas positive values are used for sites
which contribute unfavorably to the hydration free energy. [9]
In this study, almost all hydration sites identified by HSA inside the binding site are
energetically unfavorable. The strength of AGBNP2 hydration site spheres, thus having
positive hs values are used to define unfavorable water molecules in the binding site of the
receptor, which, when displaced by the ligand, contribute favorably to binding. The hs
energy values are obtained from the explicit solvent HSA analysis as described above and
are listed in Table 2.
Absolute binding free energies of the dopamine D3 receptor bound to (-)-stepholidine
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C3 analogues were calculated by means of a Single Decoupling (SDM) binding free energy
approach [50] employing an alchemical potential energy function of the form:
Uλ(r) = U0(r) + λu(r) (5)
where r = (rR, rL) are the atomic coordinates of the receptor-ligand complex, U0 represents
the effective potential energy of the uncoupled complex when receptor and ligand are not
interacting (such as if they were at infinite separation), λ is the alchemical progress parameter
which linearly couples receptor and ligand through the binding energy function u(r), defined
as the change in the effective potential energy of the complex for bringing the receptor and
ligand from infinite separation to the conformation r. Based on eq. (5), the complex is
uncoupled at λ = 0 and coupled at λ = 1. The free energy difference between these two
states is defined as the excess free energy of binding, ∆Gb. [51]
The binding free energy calculation protocol entails simulating the system at series of
λ values spaced between 0 and 1 and collecting binding energy samples at each state. The
binding energy values from each λ state are then processed using UWHAM [52] to obtain the
excess free energy of binding ∆Gb and corresponding uncertainty. The standard free energy
of binding ∆G◦b is obtained by adding the concentration and binding site volume term to the
excess free energy (see Computational Details).
Average interaction energies ∆Eb for analysis are obtained by averaging the binding
energy values of the complexes from the ensemble of conformations at the bound state at
λ = 1. The uncertainties of binding energy values are estimated from the standard error of
the mean. The reorganization free energies for binding, defined as ∆G◦reorg = ∆G◦b − ∆Eb,
are obtained from the corresponding values of the standard binding free energy and of the
binding energy. The uncertainty of the reorganization free energy is obtained by standard
error propagation.
As an alternative to simulating each alchemical λ state independently, to accelerate
the convergence of free energy calculations, in this work we utilize an Hamiltonian replica-
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exchange approach [53,54] where λ values are exchanged between molecular dynamics repli-
cas, allowing the mixing of intermolecular degrees of freedom to explore the conformational
space efficiently. [53]
Computational Details
Hydration Site Analysis (HSA) in explicit solvent
Three D3 representative receptor structures were used for the Hydration Site Analysis (HSA)
in explicit solvent. The receptor structures considered are those corresponding to the com-
plexes of D3 with (-)-stepholidine, C3 butyl (1c) and C9 butyl derivatives [22] as obtained
from individual induced fit docking (IFD) simulations [55] using the crystal structure recep-
tor configuration of the dopamine D3 receptor (PDB ID - 3PBL) as a starting point. The
IFD protocol was performed in five steps: generation of ligand conformations, initial docking
with reduced receptor atom van der Waal radii, side chain minimization with Prime [56,57], a
second docking step using the new receptor configuration and finally pose scoring. Receptor-
ligand configuration with the highest IFD score ranking was selected, except in the case where
the highest scored pose did not maintain the well conserved Asp 1103.32 salt-bridge. The apo
receptor structure from each highest scored pose, was then used for Hydration Site Analysis
(HSA).
The explicit solvent simulations for Hydration Site Analysis (HSA) were conducted with
the AMBER [58] software package with the OPC [42] water model with positional restraints
on all heavy atoms with a force constant of 10.0 kcal/mol/A˚2. Each system was minimized
and thermalized for 2.0 ns under NPT conditions of 1 atm and 300K. During the production
run, MD simulations were performed for 10.0 ns under NVT conditions and snapshots of
the trajectory were collected every 1.0 ps. High density spherical regions of 1A˚ radius were
identified using a clustering analysis on the water molecules which lies within 8 A˚ of the
superimposed ligand in D3 binding site. Individual hydration sites were then populated
with all water molecules that lies within 1 A˚ of the corresponding hydration site center.
13
Average solvation energies were calculated for each site by calculating the energies of the
water molecules within 1 A˚ of each hydration site center in all 10,000 frames of the trajectory.
For technical reasons, HSA employed a different force field (AMBER ff14SB force field [59])
than that for the binding free energy calculations (OPLS/AA). The purpose of HSA is to
obtain semi-quantitative estimates of the energies of enclosed water molecules as well as
their locations. On a qualitative level, The large increase of binding affinities when including
enclosed hydration effects (observed below) is not expected to depend on the choice of the
force field.
System preparation for the binding free energy calculations
The bound ligand was removed from the co-crystallized structure of Dopamine D3 receptor
with eticlopride [27] along with crystallographic waters. Protonation states were adjusted
to reflect neutral pH conditions. The receptor structure was prepared using the Protein
Preparation Wizard of the Maestro version 2016-3 (Schrodinger Inc.). The prepared protein
structure was used to generate the receptor grid for docking using default parameters. Dock-
ing was performed with Standard Precision (SP) version of the Glide program (Schrodinger
Release 2016-3). [60] Positional constraints were applied to the alkyl nitrogen of the (-)-
stepholidine and all the analogues to maintain the salt-bridge interaction with Asp 1103.32
of the D3 receptor. The hydroxyl and thiol groups of the receptor, such as of residues Ser
182ECL2, Ser 1925.42, Ser 1965.46, Thr 1153.37, Thr 3697.39, Cys 1143.36 located near the binding
site were allowed to rotate during docking.
The (-)-stepholidine C3 analogues were built using the Maestro program (Schrodinger
Release 2016-3). Alternative protonation states as well as chiral forms were generated for
the 7 ± 2 pH range using the LigPrep facility (Schrodinger Inc.) and ionization penalties
were calculated with Epik [61] at pH 7. The ionization free energies were recorded and added
to the binding free energy estimates to compute the predicted binding free energies. Only
states where the alkyl nitrogen is protonated were selected for docking calculations. We also
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included in the docking study the two chiral forms of the protonated alkyl nitrogen for each
compound as generated by LigPrep (Schrodinger Release 2016-3).
Binding poses generated by docking were selected based on their docking scores and pres-
ence of an ionic interaction between the protonated alkyl nitrogen and the carboxylate group
of Asp1103.32. The derivatives considered here are all stereoisomers with the S configuration
at the chiral carbon connecting ring B and ring C of the (-)-stepholidine core (Table 1).
The adjacent protonated alkyl nitrogen atom is found always in the S configuration while
maintaining the salt-bridge interaction.
The starting conformations of complexes from docking underwent energy minimization
and thermalization. Hamiltonian Replica-exchange Molecular dynamics simulations were
performed starting from the thermalized structures using 28 intermediate lambda states
distributed as follows: 0.0, 0.002, 0.005, 0.008, 0.009, 0.01, 0.0105, 0.012, 0.0135, 0.015, 0.02,
0.0225, 0.025, 0.03, 0.035, 0.04, 0.07, 0.1, 0.25, 0.35, 0.45, 0.55, 0.65, 0.71, 0.78, 0.85, 0.92,
and 1.0. The volume of the binding site, Vsite is defined as the spherical volume in which the
center of mass of ligand is within 3.5 A˚ of the center of mass of the binding site of the D3
receptor, defined as the center of mass of the Cα atoms of the residues 110, 111, 114, 183, 188,
346, 349 and the Cβ atoms of residues 342, 349 and the backbone nitrogen atom of residue
111. The binding site volume restraint is implemented as a flat-bottom spherical harmonic
potential with force constant of 3 kcal/mol/A˚2 and tolerance of 3.5 A˚ which resulted in a
free energy penalty ∆G◦t for transferring the ligand from a solution of concentration C◦ to a
volume of size Vsite, of about 1.32 kcal/mol, calculated from the following expression:
∆G◦t = −kBT lnC◦Vsite (6)
The receptor conformation was loosely restrained to the crystallographic structure using
flat-bottom positional restraints with a force constant of 25 kcal/mol/A˚2 and a tolerance of
1.5 A˚ applied to the backbone Cα atoms, except for six residues 180-185 of the ECL2 loop
to account for its flexibility.
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Temperature replica-exchange simulations were carried out to obtain conformational
reservoirs of the apo receptor. [62] These utilized 23 replicas distributed between 300 and
400K. [62] The conformational ensemble collected at 300K was used as a source of apo-
receptor conformations in the replica-exchange simulations. Conformational reservoirs for
each ligand were generated similarly using 8 replicas distributed between 300 and 600K.
During the simulation, conformations of receptor and ligands were randomly selected from
the conformational reservoirs during exchanges at the fully uncoupled state.
Single-decoupling binding free energy calculations were performed for approximately 1
ns per replica for a total of 28 ns per complex. Binding energies samples from the last 500
ps were used for the binding free energy estimates. Each cycle of replica lasted 10 ps with
1 fs MD time-step. Binding energies were collected every 10 ps. Most of the calculations
were carried out at the XSEDE SuperMIC and Stampede2 clusters utilizing CPU’s and MIC
devices.
To improve the convergence of the binding energies near the uncoupled state at λ = 0,
we employ a soft core binding energy function as described elsewhere. [52, 63] The binding
energies were analyzed using the UWHAM R-statistical package [52] to yield the binding
free energy ΔG◦b. As mentioned, the average interaction energy ΔEb of each complex was
obtained from the value of the average binding energy at the coupled state (λ = 1). Re-
organization free energies ΔG◦reorg were measured as the difference between the binding free
energy and the average binding energy as ∆G◦reorg = ∆G◦b −∆Eb.
Synthesis and experimental assays of (-)-stepholidine C3 analogues
Compounds 1a-1f were synthesized using the procedure developed as shown in Supplemen-
tary Fig. S1. Commercially available dihydroxy benzaldehyde, 4 was selectively protected
with a benzyl group to give compound 5. Second, the phenolic group of aldehyde 5 was
protected with a silyl group and the intermediate was subjected to a Henry condensation
reaction to give nitrostyrene 6. Reduction of nitro compound 6 using LiBH4 yielded primary
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amine 7. Aminolysis of lactone 8 with primary amine 7 was carried out to give amide alco-
hol 9, which was acetylated to afford 10. Ring B of the tetrahydroprotoberberine (THPB)
scaffold was formed via Bischler-Napieralski cyclization followed by asymmetric hydrogena-
tion using Noyori’s catalyst and formic acid/triethylamine mixture to generate 11 with good
yield (88%). Hydrolysis of the acetyl group and subsequent chlorination endowed us the
tetracyclic scaffold of THPB in compound 12. The enantiomeric excess of this common pre-
cursor was found to be 90.2% (chiral HPLC) and it was used for further analogue generation.
Alkylation of compound 12 followed by debenzylation provided us the C3 analogues 1a-1f.
All the (-)-stepholidine C3 analogues were biochemically evaluated by primary and sec-
ondary radioligand binding assays with the dopamine receptor to obtain the inhibition con-
stants of binding, Ki and reported in Table 3. Both the primary and secondary radioligand
binding assays were done at the PDSP facility (http://pdsp.med.unc.edu/). In the primary
binding assays, compounds were tested at single concentrations (10 μM) in quadruplicate in
96-well plates. Compounds that showed a minimum of 50% inhibition at 10 μM were tagged
for secondary radioligand binding assays to determine equilibrium binding affinity at specific
targets. In the secondary binding assays, selected compounds were tested in triplicate sets (3
sets of 96-well plates) at eleven different concentrations out of which eight are in nanomolar
range (0.1, 0.3, 1, 3, 10, 30, 100 and 300 nM) and rest of the three concentration in micro-
molar range (1, 3, and 10 μM). Both primary and secondary radioligand binding assays were
carried out in a final of volume of 125 μl per well in appropriate binding buffer. The hot
ligand concentration was usually at a concentration close to the Kd (unless otherwise indi-
cated). Total binding and nonspecific binding were determined in the absence and presence
of 10 μM Chlorpromazine, which was used as a reference compound. In brief, plates were
usually incubated at room temperature and in the dark for 90 min. Reactions were stopped
by vacuum filtration onto 0.3% polyethyleneimine (PEI) soaked 96-well filter mats using a
96-well Filtermate harvester, followed by three washes with cold wash buffer. Scintillation
cocktail was then melted onto the microwave-dried filters on a hot plate and radioactivity
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was counted in a Microbeta counter. For detailed experimental details, please refer to the
PDSP website http://pdsp.med.unc.edu/ and click on ‘Binding Assay’ or ‘Functional Assay’
on the menu bar.
Results
Biochemical evaluation of (-)-stepholidine C3 analogues
The inhibition constants for binding of the C3 analogues are reported in Table. 3. The
C3 analogues showed relatively stronger inhibition of binding at the dopamine D3 receptor
compared to that of C9 analogues tested previously. [22] The length of the C3 substitution
has generally a small influence on their measured affinities in this set. However, the analogues
with the longest C3 pentyl and hexyl substituent (1d and 1e) exhibit a slightly stronger
affinity (Table 3)
Table 3: Measured inhibition constants of binding (Ki) for the (-)-stepholidine C3 analogues
against the dopamine D3 receptor.
Compounds C3-substituent Ka,bi
1a Et 40.0
1b n-Pr 46.0
1c n-Bu 51.0
1d n-Pen 33.0
1e n-Hex 26.0
1f 2-fluroethyl 86.0
a In nM. Experiments were carried out in triplicate - uncertainties are estimated as 13% of reported Ki; b[3H]
N-methylspiperone used as radioligand; chlorpromazine used as a reference compound with Ki = 11.0 nM. The biochemical
details of the assay are provided in the main text.
Binding Free Energy Calculations
We employed the enclosed hydration model described above to study six derivatives of (-
)-stepholidine substituted at the C3 position with and without the enclosed hydration cor-
rections to probe the effects of enclosed hydration on the binding free energy predictions
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Figure 5: a) The C3 pentyl analogue (3e, purple) of (-)-stepholidine is observed to interact
with Ser 192 of the receptor at the orthosteric binding site. In order for the C3 analogues to
interact with Ser 192, the C10 hydroxyl group is placed in proximity of Ser 192; b) The 3e
C3 analogue in another observed binding pose in which it interacts with Ser 196, rather than
Ser 192. In this pose, ring D of the (-)-stepholidine core is bound deeper into the orthosteric
binding site and the ligand is twisted causing Tyr 365 in the SBS to rotate and move away
from Ser 182 of ECL2. The receptor is represented as a pink ribbon.
(Table 4).
The (-)-stepholidine C3 analogues are substituted at the third position of ring A of the
(-)-stepholidine core. To accommodate the long alkyl chain substituents, the C3 analogues
(Fig. 5) are found to dock to the dopamine D3 receptor in a binding pose so that the alkyl
chain occupies the secondary binding site (SBS). This has the important consequence that
ring D, occupies the OBS so to maintain the salt bridge with Asp 1103.32 in contrast to C9
analogues where ring A occupy the OBS [22].
The enclosed hydration model is found to be an essential ingredient to reproduce the ob-
served affinities. Binding free energy estimates of C3 derivatives obtained without enclosed
hydration grossly underestimate the magnitudes of the experimental affinities derived from
the measured inhibition constants of binding (Table 4, 2nd and 3rd columns). In contrast,
binding free energy calculated with the enclosed hydration model are significantly more favor-
able and substantially in better quantitative agreement with the experiments than without
enclosed hydration (Table 4, 2nd and 6th columns). When employing the enclosed hydration
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model, the root mean square error (RMSE) is reduced by a factor of 6 and, while variations
in the experimental values are slight (Table 4, 2nd column), the level of correlation increased
from less than zero to 64%. The values of the calculated binding free energies with enclosed
hydration are all within 2 kcal/mol of the experiments.
Table 4: Experimental and calculated binding free energies, average binding energies and
reorganization free energies of the (-)-stepholidine C3 analogues with and without enclosed
hydration corrections.
Compound ∆G◦
a,b
exp Without enclosed hydration model With enclosed hydration model
∆G◦
b,c
calc ∆E
b,c
b ∆G
◦b,c
reorg ∆G
◦b,c
calc ∆E
b,c
b ∆G
◦b,c
reorg
1a −10.1 −2.2 −36.9 34.7 −8.8 −42.5 33.7
1b −10.0 −2.3 −38.0 35.7 −10.4 −44.7 34.3
1c −10.0 −1.8 −40.3 38.5 −11.5 −48.1 36.6
1d −10.2 −0.3 −43.7 43.4 −10.6 −55.6 45.0
1e −10.4 −3.9 −39.6 35.7 −12.5 −55.2 42.7
1f −9.6 −3.1 −32.7 29.6 −8.9 −43.2 34.3
RMSEb,d 7.9 1.2
Correlation coefficient (r) −0.014 0.64
a Experimental affinities are calculated using the relation ∆G◦exp = kBT lnKi where Ki is the inhibition constant of binding,
kB is the Boltzmann’s constant. bIn kcal/mol. cApproximate uncertainties for all measurements are implied by the number of
significant figures; the actual values of the uncertainties for each measurement are provided in Supplementary Table ST3.
dRoot mean square error relative to the experimental binding free energies.
Discussion
Though efficient and faster convergence of binding free energy calculations can be achieved
using implicit solvent models, these lack the ability to model solvent heterogeneity and
confinement in molecular simulations, especially within deep protein binding pockets. In ab-
sence of ligand, enclosed water molecules form network of interactions among themselves and
with receptor atoms, which are fundamentally different from those present in the bulk and
solvent exposed regions of the protein. [8,11] Water molecules which maintain favorable con-
tacts with the protein or act as bridging waters generally disfavor binding when displaced by
the ligand. However, enegetically and entropically frustrated water molecules such as those
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trapped within the hydrophobic regions of the binding site, favor binding when displaced
by the ligand. In this work, we have employed for the first time a hybrid computational
model involving explicit and implicit solvation to include the thermodynamics of confined
water in the calculation of the binding free energies of protein-ligand complexes. We applied
the model to calculate the binding free energies for a series of novel compounds as potential
ligands of the dopamine D3 receptor, which have been synthesized and assayed for activity
as part of this work. In all cases tested, binding free energies were observed to be more
favorable in the presence of enclosed hydration effects compared to the conventional implicit
solvent model. The enhancement of binding affinities with the enclosed hydration model is
in accord with the idea that energetically frustrated enclosed water molecules contributed
favorably to binding when displaced by the ligand.
In this study, we identify a class of dopamine D3 receptor ligands which are more powerful
than those previously synthesized and assayed. [22] The affinities of the (-)-stepholidine
C3 analogues, synthesized in this work, justifies the motivation of synthesis to increase
interaction at the secondary binding site (SBS) by adding substituents at the C3 position,
with the strongest affinitiy being observed for the longest substitution (1e) in agreement
with the computational predictions (Table 3). The modeling approach introduced here has
provided key insights for this system. All of the compounds analyzed consistently maintained
an ionic interaction between the protonated alkyl nitrogen of the (-)-stepholidine core and
the carboxylate group of Asp1103.32 of the D3 receptor.
The positioning of C3 analogues within the binding site affect not only the pattern of
ligand-receptor interactions in the secondary binding site, but crucially, also the interac-
tions within the orthosteric pocket as well as the pattern of displacement of energetically
unfavorable water molecules (Fig. 6). These energetic and structural features are ultimately
reflected in the differences of binding affinities with and without enclosed hydration effects
(Table 4). When not considering enclosed hydration effects, the calculated binding affinities
of the C3 analogues are observed to be very overly unfavorable. Inclusion of the enclosed
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hydration effects in the calculation, made the calculated binding free energies more favorable
and improved the agreement with the experimental values (Table 4).
In our model, ring D of the (-)-stepholidine C3 analogues is placed into the orthosteric
binding pocket where it is observed to interact with Ser 1925.42 through one hydrogen bond
interaction with the hydroxyl group at position C10. In addition, the hydrogen bond in-
teraction of C3 analogues is not stably maintained throughout the simulation, as it is seen
to periodically switch to an alternate hydrogen bonding interaction with Ser 1965.46 slightly
deeper into the orthosteric binding site (Fig. 5b). Also, the binding of C3 analogues is ob-
served to displace almost all enclosed water molecules within the orthosteric binding site by
placing the (-)-stepholidine core. However, while interacting with Ser 1965.46, the alkoxy sub-
stituent chain at the secondary binding site (SBS) displaced fewer enclosed water molecules.
These enclosed water sites, however, impose less energetic penalties, totaling to less than 1.5
kcal/mol (sites 11 and 14, see Table 2 and Fig. 6), thereby contributing to little difference
in the calculated binding affinities between the C3 derivatives. Another interesting obser-
vation in this pose is the displacement of Tyr 3657.35 of helix VII away from the secondary
binding site (Fig. 5b) and the concurrent disruption of the hydrogen bond interaction with
Ser 182ECL2 which stabilizes the extracellular loop 2 (ECL2) in the SBS.
Conformational changes within the binding site may change the number and pattern of
ligand-receptor interactions [64] as well as the hydration structure, which we know to be very
sensitive to the placement of receptor atoms. All calculations were done in absence of the
description of the cellular membrane while limiting large backbone motions. Despite these
limitations, our computational protocol was able to correctly predict the affinities of the C3
analogues with reasonable accuracy.
All these observations illustrates the complexities associated with binding of the (-)-
stepholidine analogues to the dopamine D3 receptor. They also underscore the challenges
encountered in the design of effective and selective D3 ligands/antagonists. [20, 22, 24, 34,
36, 65] One major challenge is the effect of the specific remodeling of the receptor binding
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Figure 6: Representative bound poses of (-)-stepholidine C3 analogues (purple) interacting
with Ser 196 at the orthosteric binding site of the dopamine D3 receptor is observed to
displace fewer enclosed water molecules, especially at the secondary binding site. AGBPN2
sites 11 and 14 are not displaced in this conformation of the C3 analogues (Table 2).
site induced by ligands. In our study, induced fit docking calculations have not revealed
major structural changes for different (-)-stepholidine analogues, although Hydration Site
analysis (HSA) revealed more significant changes in the hydration energies and location of
the hydration sites. The modeled binding affinities of the C3 analogues in this work may
reflect the limitations imposed by the initial receptor structure. Another computational
challenge in this work has been the appropriate representation of the enclosed hydration
sites by exploiting the available topologies afforded by the current AGBNP2 implicit solvent
model.
Conclusion
In this study, we exploited the energetics of confined water molecules as obtained from
explicit solvent simulations, and trained an implicit solvent model to account their effects
on protein-ligand binding free energies, using a hybrid approach which proved useful for
host-guest binding thermodynamics. [9]
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Protein binding sites are much more complex than host-guest systems both in terms of
structure and conformational variability. This is the first report of the implementation of a
hybrid explicit-implicit solvent approach to calculate the binding affinities of protein ligand
complexes and its application to a series of complexes of the dopamine D3 receptor. As we
have illustrated, it is very challenging to model with high confidence the thermodynamics
of enclosed water molecules in protein binding sites. While more research is needed to
improve and automate model parameterization and model accuracy, this study confirms
that it is both useful and viable to include enclosed hydration effects in binding free energy
calculations with implicit solvation as an alternative to explicit modeling, which is more
affected by slow equilibration. [66–68]
The experimental dissociation constants and the computational modeling work have pro-
vided valuable insights for the design of stronger and specific ligands of the dopamine D3
receptor. This study emphasizes the benefits of interdisciplinary approaches by tackling
difficult rational drug design problems from different experimental, synthetic and modeling
sides.
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